MFSL

Life Insurance

Max Financial Services Limited

NSE: MFSLBSE: 500271ISIN: INE180A01020
₹1,515.50
+11.60 · +0.77%
As of 24 Jul 2026
Open
₹1,497.50
High
₹1,520.80
Low
₹1,484.80
Prev Close
₹1,503.90
52W High
₹1,892.50
52W Low
₹1,433.60
Volume
11.13 L
Mkt Cap
₹52,338 Cr
Fundamentals
Valuation & profitability
Market Cap
₹52,338 Cr
P/E Ratio
105
EPS (TTM)
₹14.43
Book Value
₹112.00
Dividend Yield
0%
ROCE
9.77%
ROE
9.21%
Sales Growth
14%
Face Value
₹2.00
Company overview
Max Financial Services Limited

MFSL or Max India was incorporated in 1988, and it is a multi-business enterprise. Also, the company has a business interest in the sectors of life insurance, healthcare, and clinical research.

Also, the company has subsidiaries such as Max New York Life - a joint venture between Max India and New York Life; and Max Healthcare – that is engaged in providing healthcare services; and Max Bupa Health Insurance, which is a joint venture between Max India and Bupa Finance Plc. Also, the UK involved in the clinical research business and the Max Neeman – a manufacturer of specialty products for the industry of packaging.

The Company also operates via 555 offices across more than 364 locations in the country. The company has an employee strength of approximately 92,000 people. It also has various divisions that have received ISO 9001:2000 and IS014001: 2004 certifications for their quality management.

Earlier, the company had a business interest in several sectors of electronic component distribution, plating the chemicals, and penicillin-based bulk drugs and also the generic bulk drugs. But, later the company divested its business interests in such businesses.

Max New York Life (MNYL) – Under this segment, the company has a joint venture between Max India and New York Life and was incorporated in the year 2000. Also, the company offers a spectrum of products in both individual and group life insurance solutions. Currently, it is among the leading private sector life insurance industries.

Max Healthcare (MHC) – Under this segment, the company has a division that operates in 8 hospitals located in both Delhi and NCR. Such hospitals offer services in the area of orthopedics and joint replacement, pediatrics, neurosciences, obstetrics and gynecology, aesthetic and reconstructive plastic surgery and internal medicine.

Key highlights
Auto-generated from live data
  • Trades at a P/E of 105, with a return on equity (ROE) of 9.21%.
  • MFSL is trading below all of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
  • Year-to-date it is down 9.65%, and down 10.38% over the past year.
  • At ₹1,515.50 it sits about 18% of the way up its 52-week range (₹1,433.60–₹1,892.50).
  • Market capitalisation stands at ₹52,338 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern

Shareholding data syncs daily.

Performance
Stock returns vs Nifty 50
10D
-5.33%
Nifty -0.64%
20D
-4.54%
Nifty -1.72%
50D
-2.41%
Nifty +2.68%
100D
-10.16%
Nifty -1.14%
200D
-10.00%
Nifty -8.93%
YTD
-9.65%
Nifty -8.59%
52W
-10.38%
Nifty -7.86%
Moving averages
Simple moving averages vs current price
0/5 above · Bearish
SMA 10-Day
₹1,559.61Below
SMA 20-Day
₹1,578.26Below
SMA 50-Day
₹1,610.39Below
SMA 100-Day
₹1,628.32Below
SMA 200-Day
₹1,646.66Below
Price ranges
Where the price sits in each window
10-Day range₹1,515.50
₹1,484.80₹1,662.00
20-Day range₹1,515.50
₹1,484.80₹1,662.00
50-Day range₹1,515.50
₹1,484.80₹1,748.00
200-Day range₹1,515.50
₹1,433.60₹1,892.50
YTD range₹1,515.50
₹1,433.60₹1,892.50
52-Week range₹1,515.50
₹1,433.60₹1,892.50
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Up On 14 May, 2025 : 1317.70 ~ 1301.00SUPPORT
Unfilled Gap Up On 12 May, 2025 : 1280.50 ~ 1271.20SUPPORT
Unfilled Gap Up On 25 Aug, 2020 : 580.00 ~ 565.00SUPPORT
Annual financials
Revenue, profit & EPS by financial year
YearRevenueNet ProfitEPSNPM
Mar 2023₹58 Cr₹14 Cr₹0.4024.14%
Mar 2022₹200 Cr₹103 Cr₹2.9751.5%
Mar 2021₹31,275 Cr₹425 Cr₹12.331.36%
Mar 2021₹31,275 Cr₹425 Cr₹12.331.36%
Mar 2020₹18,240 Cr₹145 Cr₹5.380.79%
Mar 2020₹18,240 Cr₹145 Cr₹5.380.79%
Mar 2019₹19,498 Cr₹263 Cr₹9.751.35%
Mar 2019₹19,498 Cr₹263 Cr₹9.751.35%
Mar 2018₹16,338 Cr₹286 Cr₹10.671.75%
Mar 2017₹15,247 Cr₹395 Cr₹14.792.59%
Mar 2016₹11,710 Cr₹253 Cr₹7.572.16%
Mar 2015₹14,907 Cr₹280 Cr₹8.961.88%
Peer comparison
Other companies in Life Insurance
CompanyP/EBook ValueSales Growth
HDFCLIFE
HDFC Life Insurance Company Ltd
87.38₹31.4828.36%
SBILIFE
SBI Life Insurance Company Ltd
67.52₹84.8532.16%
ICICIPRULI
ICICI Prudential Life Insurance Company Ltd
59.56₹52.3625.76%
Dividend history
Per share, by ex-date
Ex-Date: 19 Sept 2016₹1.80
Ex-Date: 19 Nov 2015₹1.80
Ex-Date: 15 Sept 2015₹1.00
Ex-Date: 25 Nov 2014₹4.00
Ex-Date: 12 Sept 2014₹1.80
Ex-Date: 21 Nov 2013₹1.80
Ex-Date: 10 Sept 2013₹2.20
Ex-Date: 22 Nov 2012₹10.00
Ex-Date: 23 Aug 2001₹3.50
Bulk & block deals
Recent large transactions
DateClientTypeQtyPrice
29 Mar 2023MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITEDSALE30,00,000₹606.60
29 Mar 2023PLUTUS WEALTH MANAGEMENT LLPPURCHASE20,00,000₹606.60
29 Mar 2023MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITEDSALE10,00,000₹606.60
29 Mar 2023MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITEDSALE20,00,000₹606.60
29 Mar 2023PLUTUS WEALTH MANAGEMENT LLPPURCHASE10,00,000₹606.60
29 Mar 2023PLUTUS WEALTH MANAGEMENT LLPPURCHASE20,00,000₹606.60
03 Nov 2022ISHARES CORE EMERGING MARKETS MAURITIUS COSALE3,41,721₹720.45
03 Nov 2022ISHARES CORE MSCI EMERGING MARKETS ETFPURCHASE3,41,721₹720.45
25 Oct 2022ISHARES CORE EMERGING MARKETS MAURITIUS COSALE1,83,846₹698.80
25 Oct 2022ISHARES CORE MSCI EMERGING MARKETS ETFPURCHASE1,83,846₹698.80
25 Oct 2022ISHARES INDIA SC MAURITIUS COMPANYSALE1,34,881₹698.80
25 Oct 2022ISHARES MSCI INDIA SMALL-CAP ETFPURCHASE1,34,881₹698.80

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.